With the support of a new grant from the Department of Energy , Patrick Underhill, a professor of chemical and biological engineering, will examine polymer performance through the use of models and simulations.

Carbon capture technologies play a critical role in reducing greenhouse gas emissions from power plants and factories, while harnessing carbon dioxide (CO2) for other energy production. With the support of a grant from the Department of Energy, Miao Yu, the Priti and Mukesh Chatter ’82 Career Development Chair of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, will develop a novel porous material capable of capturing even very small concentrations of CO2 in the air and collecting the gas for further use

The third season of Why Not Change the World? The RPI Podcast kicks off this week with a deep dive on a research project aimed at making self-disinfecting masks — an urgent need in the ongoing COVID-19 pandemic.

Each year tens of millions of tons of plastic are sent to landfills, while another 8 million metric tons of plastic end up in the ocean. It’s an exponential problem that requires an environmentally friendly solution.

A new program in Biotechnology and Health Economics at Rensselaer Polytechnic Institute will equip students destined for a science-based career with the quantitative and modeling knowledge in economics needed to succeed in industry and consulting.

TROY, N.Y. — With COVID-19 still spreading in the United States, where it has already killed more than 140,000 people, improved screening and treatment options are critically important for high-risk patients with comorbidities, such as diabetes, pulmonary disease, and cardiovascular disease.

In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease.

Ryan Gilbert, a professor of biomedical engineering at Rensselaer Polytechnic Institute, will serve as a member of the Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section for the National Institutes of Health Center for Scientific Review.

A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.

New research, published online today in Developmental Cell, shows that PRC1 – a protein that serves as a telltale sign in many cancer types, including prostate, ovarian, and breast cancer – acts as a “viscous glue” during cell division, precisely controlling the speed at which two sets of DNA are separated as a single cell divides.